Showing results (261-270 of 313) with videos related to
Sort By:
Pageof 32
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypesAndres M Acosta, Lynette M Sholl, Brendan C Dickson, et al.Human Pathology|May 29, 2017
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overviewMarkku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)Yu-Chien Kao, Akihiko Yoshida, Tsung-Han Hsieh, et al.Cancer Research|July 19, 2002
Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study GroupFredrik Mertens, Ulf Strömberg, Nils Mandahl, et al.International Journal of Surgical Pathology|June 21, 2002
Diagnosis of gastrointestinal stromal tumors: a consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.Genes, Chromosomes & Cancer|February 17, 2012
Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genesYuesheng Jin, Emely Möller, Karolin H Nord, et al.Human Pathology|July 3, 2002
Diagnosis of gastrointestinal stromal tumors: A consensus approachChristopher D M Fletcher, Jules J Berman, Christopher Corless, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumorsAndrew J Wagner, Izabela Malinowska-Kolodziej, Jeffrey A Morgan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITCharles D Blanke, George D Demetri, Margaret von Mehren, et al.Pageof 32